Abiomed ABMD
$ 381.02
0.0%
Quarterly report 2022-Q3
added 11-03-2022
Country |
USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Michael Minogue |
Employees in the company |
1 536 |
Shares |
45.1 K |
Market Cap[1] |
$ 17.2 B |
EBITDA (LTM) |
$ 333 M |
P/E (LTM) |
46.87 |
P/S (LTM) |
13.03 |
EPS (LTM) |
8.13 |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.